| [F1–02–02]: DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION S Westwood, A Hye, A Lleó, AJ Nevado‐Holgado, AL Baird, A Wallin, ... Alzheimer's & Dementia 13 (7S_Part_3), P174-P175, 2017 | | 2017 |
| [F1–04–04]: EUROPEAN MEDICAL FRAMEWORK FOR ALZHEIMER'S DISEASE PJ Visser Alzheimer's & Dementia 13 (7S_Part_3), P178-P179, 2017 | | 2017 |
| [IC‐P‐036]: CORRELATION OF GREY MATTER NETWORK MEASURES IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS M Kate, BM Tijms, E Konijnenberg, A den Braber, DI Boomsma, ... Alzheimer's & Dementia 13 (7S_Part_1), P32-P32, 2017 | | 2017 |
| [IC‐P‐053]: EARLY ALTERATIONS IN RESTING‐STATE FUNCTIONAL CONNECTIVITY IS ASSOCIATED WITH AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWINS A den Braber, N Prent, M Kate, E Konijnenberg, F Barkhof, ... Alzheimer's & Dementia 13 (7S_Part_1), P43-P44, 2017 | | 2017 |
| [IC‐P‐167]: ACROSS‐SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI‐SITE 3T STUDY F Ribaldi, M Marizzoni, J Jovicich, C Ferrari, B Bosch, D Bartrés‐Faz, ... Alzheimer's & Dementia 13 (7S_Part_2), P126-P127, 2017 | | 2017 |
| [O1–05–03]: CSF AMYLOID BETA 1–42 LEVELS OBTAINED OVER 15 YEARS SHOW A DIAGNOSIS‐DEPENDENT UPWARD DRIFT BM Tijms, SD Mulder, PJ Visser, WM van der Flier, P Scheltens, ... Alzheimer's & Dementia 13 (7S_Part_4), P198-P199, 2017 | | 2017 |
| [O2‐04‐06]: Frequency of MCI subtypes in a clinical setting. The DESCRIPA study PJ Visser Alzheimer's & Dementia 1, S102-S103, 2005 | | 2005 |
| [O2–05–01]: Twin correlations for amyloid pathology measured with positron emission tomography and in cerebrospinal fluid in cognitively healthy elderly monozygotic twin pairs E Konijnenberg, A den Braber, M Kate, S Adriaanse, MM Yaqub, ... Alzheimer's & Dementia 13 (7S_Part_11), P559-P560, 2017 | 2 | 2017 |
| [O2–12–03]: DURATION OF ALZHEIMER's DISEASE IN THE PRECLINICAL, PRODROMAL AND DEMENTIA STAGE: A MULTI‐STATE MODEL ANALYSIS L Vermunt, SAM Sikkes, A van den Hout, R Handels, I Bos, ... Alzheimer's & Dementia 13 (7S_Part_11), P585-P586, 2017 | 6 | 2017 |
| [O3–06–03]: THE IMPACT OF AMYLOID AND TAU PATHOLOGY ON THE DEVELOPMENT OF SUBTLE COGNITIVE CHANGES IN PERSONS WITHOUT DEMENTIA WJ Jansen, R Ossenkoppele, PJ Visser, Amyloid Biomarker Study Group Alzheimer's & Dementia 13 (7S_Part_18), P912-P912, 2017 | | 2017 |
| [O3–10–03]: LONGITUDINAL CEREBROSPINAL FLUID BIOMARKER TRAJECTORIES ALONG THE ALZHEIMER'S DISEASE CONTINUUM: A MULTICENTRE EUROPEAN STUDY A Lleó, D Alcolea, P Martinez‐Lage, P Scheltens, L Parnetti, J Poirier, ... Alzheimer's & Dementia 13 (7S_Part_19), P924-P924, 2017 | 3 | 2017 |
| [O5–03–01]: PREDICTING THE HEALTH ECONOMIC IMPACT OF EARLY TREATMENT IN PRE‐DEMENTIA ALZHEIMER's DISEASE R Handels, L Vermunt, SAM Sikkes, M Potashman, J Bobula, J Berkhof, ... Alzheimer's & Dementia 13 (7S_Part_30), P1457-P1457, 2017 | 1 | 2017 |
| [P‐010]: Predictive accuracy of the extended Predementia Alzheimer disease Scale (PAS) for Alzheimer‐type dementia in subjects with MCI PJ Visser, N Schoonenboom, J Lindeboom, F Bouwman, L van de Pol, ... Alzheimer's & Dementia 1, S12-S12, 2005 | 1 | 2005 |
| [P1–250]: DECISION TREE ANALYSIS REVEALS TWO CUT‐OFF LEVELS FOR AMYLOID BETA IN EARLY AD DIAGNOSIS RB Mofrad, NSM Schoonenboom, BM Tijms, DL Knol, P Scheltens, ... Alzheimer's & Dementia 13 (7S_Part_7), P342-P343, 2017 | | 2017 |
| [P1–289]: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID‐PET) IN THE EMIF‐AD BIOMARKER DISCOVERY … S Westwood, AL Baird, A Hye, I Bos, SJB Vos, R Vandenberghe, ... Alzheimer's & Dementia 13 (7S_Part_7), P361-P362, 2017 | | 2017 |
| [P1–387]: CHARACTERIZATION OF SUSPECTED NON‐ALZHEIMER's DISEASE PATHOPHYSIOLOGY (SNAP) IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT USING NEUROIMAGING SJB Vos, E Gronenschild, HIL Jacobs, I Bos, P Scheltens, ... Alzheimer's & Dementia 13 (7S_Part_8), P414-P414, 2017 | | 2017 |
| [P1–411]: WHITE MATTER HYPERINTENSITIES AND VASCULAR RISK FACTORS IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS M Kate, CH Sudre, A den Braber, E Konijnenberg, MJ Cardoso, ... Alzheimer's & Dementia 13 (7S_Part_8), P433-P434, 2017 | | 2017 |
| [P1–575]: PREVALENCE OF THE APOLIPOPROTEIN E ε4 ALLELE IN AMYLOID‐β POSITIVE SUBJECTS ACROSS THE SPECTRUM OF ALZHEIMER's DISEASE C Groot, N Mattsson, WJ Jansen, PJ Visser, R Ossenkoppele Alzheimer's & Dementia 13 (7S_Part_10), P515-P515, 2017 | | 2017 |
| [P2–194]: USING EMERGING CEREBROSPINAL FLUID MARKERS TO CHARACTERIZE SUSPECTED NON‐ALZHEIMER's DISEASE PATHOPHYSIOLOGY (SNAP) IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT SJB Vos, FRJ Verhey, M Tsolaki, LO Wahlund, G Waldemar, ... Alzheimer's & Dementia 13 (7S_Part_14), P680-P681, 2017 | | 2017 |
| [P2–212]: EUROPEAN MEDICAL INFORMATION FRAMEWORK FOR ALZHEIMER's DISEASE (EMIF‐AD): THE BIOMARKER DISCOVERY STUDY I Bos, SJB Vos, R Vandenberghe, P Scheltens, S Engelborghs, GB Frisoni, ... Alzheimer's & Dementia 13 (7S_Part_14), P691-P692, 2017 | 1 | 2017 |
